IP Library Granted Patent US 8,371,092
Granted Patent B1
US 8,371,092 · App. 12/555,602 · Granted Feb 12, 2013

Apparatus and methods for reducing capsule elongation

Inventors: David W Dodsworth (Furlong, PA); Jack Bradley (Downingtown, PA); Jeffery A Rudy (Norwich, NY); Todd M Hall (Norwich, NY); Paul Barnhart (Maryland, NY)
Assignee: Viropharma Incorporated
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,371,092
App. No.
12/555,602
Granted
Feb 12, 2013
Kind
B1
Abstract

A capsule pressure control assembly for regulating or controlling the internal pressure of filled capsules, whereby instances of capsule elongation are reduced or eliminated, thus resulting in an increased yield rate of acceptable filled capsules.

Claims (36)

1. A capsule pressure control assembly for lowering the internal pressure of a capsule, the capsule pressure control assembly comprising:

a support unit configured to cooperate with the discharge of an encapsulating machine to receive capsule containing medicine in a melted polymeric matrix at a temperature substantially higher than ambient temperature for the assembly, wherein the support unit comprises a structural unit and one or more trays having a fluid permeable floor and sidewalls, wherein the structural unit supports the one or more trays; and

a cooling device in fluid communication with said support unit operable to drive a flow of fluid through the permeable floor of the trays to impede expansion of air in the matrix in the capsules following discharge of the capsules from the encapsulating machine.

2. The capsule pressure control assembly according to claim 1 , wherein the structural unit is a cart.

3. The capsule pressure control assembly according to claim 1 , wherein the tray floor is a mesh.

4. The capsule pressure control assembly according to claim 1 , wherein the cooling device is mounted on the structural unit.

5. The capsule pressure control assembly according to claim 1 , wherein the cooling device is a fan where a volume of air is drawn past at least one filled capsule.

6. The capsule pressure control assembly according to claim 5 , wherein the volume of air ranges from about 100 CFM to about 3000 CFM.

7. The capsule pressure control assembly according to claim 5 , wherein the volume of air has a temperature ranging from about 10° C. to about 60° C.

8. The capsule pressure control assembly according to claim 5 , wherein the volume of air has a relative humidity ranging from about 10% to about 50%.

9. The capsule pressure control assembly according to claim 1 , wherein the volume of air cools the at least one capsule for at least 3 minutes.

10. The assembly according to claim 1 comprising a heating element for heating a quantity of fill material for filling capsules to an elevated temperature and an encapsulator for metering the heated fill material into capsules to form heated capsules.

11. The capsule pressure control assembly according to claim 10 wherein the cooling device is operable to reduce increased pressure caused by entrapped air in the heated capsule, to impede expansion of the capsules beyond a predetermined limit.

12. The assembly of claim 1 wherein the support unit comprises a movable transport for conveying heated capsules and the cooling device comprises one or more fans for providing forced air convection for the heated capsules, wherein the movable transport comprises a plurality of opening for allowing the convective flow through the transport.

13. The assembly of claim 12 wherein the fans are configured to provide a down draft flow over the heated capsules and through the transport.

14. The assembly of claim 12 wherein the movable transport comprises a conveyor having:

a width;

a length extending from an input at which heated capsules are loaded onto the conveyor and an output at which the capsules are discharged from the conveyor;

a top surface; and

a plurality of partitions projecting upwardly from the top surface of the conveyor, wherein the partitions have edges adjacent to or engaging the sidewalls.

15. The assembly of claim 14 wherein the cooling device comprises a plurality of movable receptacles for receiving heated capsules and conveying the heated capsules over the one or more fans, wherein each receptacle comprises:

a front wall formed by a first one of the partitions;

a rear wall formed by a second one of the partitions; and

sides formed by the sidewalls;

wherein the receptacles are formed so that front and rear walls form intersections at which any spacing between the front and rear walls and the sides is less than the smallest dimension of the capsules.

16. A capsule pressure control assembly for lowering the internal pressure of a capsule, the capsule pressure control assembly comprising:

a capsule receiving assembly configured to cooperate with the discharge of an encapsulating machine to receive capsule containing medicine in a melted polymeric matrix at a temperature substantially higher than ambient temperature for the assembly, wherein the capsule receiving assembly comprises a plurality of movable receptacles for receiving heated capsules and conveying the heated capsules toward a cooling assembly, wherein each receptacle comprises a fluid permeable floor and:

a front wall formed by a first partition;

a rear wall formed by a second partition; and

sidewalls;

wherein the receptacles are formed so that front and rear walls form intersections at which any spacing between the front and rear walls and the sides is less than the smallest dimension of the capsules; and

wherein the cooling assembly is adjacent the capsule receiving assembly and is operable to drive a flow of fluid through the permeable floor to impede expansion of air in the matrix in the capsules following discharge of the capsules from the encapsulating machine.

17. The capsule pressure control assembly of claim 16 wherein the cooling assembly is operable to cool the capsules from the time the capsule are discharged from the encapsulator until any air in the polymeric matrix material cooled sufficiently to substantially eliminate the likelihood of capsule elongation due to expansion of the air within the capsules.

18. The capsule pressure control assembly according to claim 16 , wherein the cooling device is a fan where a volume of air is drawn past at least one filled capsule.

19. The capsule pressure control assembly according to claim 18 , wherein the volume of air has a temperature ranging from about 10° C. to about 60° C.

20. The capsule pressure control assembly according to claim 18 , wherein the volume of air has a relative humidity ranging from about 10% to about 50%.

Assignments (10)
CHANGE OF NAME Recorded Jun 15, 2021
From: SHIRE VIROPHARMA INCORPORATED
To: SHIRE VIROPHARMA LLC
Reel/Frame 056596/0380 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 20, 2021
From: SHIRE VIROPHARMA LLC
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 056307/0254 →
RELEASE OF SECURITY INTEREST Recorded Jan 29, 2016
From: HSBC BANK USA, NATIONAL ASSOCIATION
To: ALVOGEN, INC.; ALMATICA PHARMA INC.
Reel/Frame 037619/0101 →
CHANGE OF NAME Recorded Jul 8, 2015
From: VIROPHARMA INCORPORATED
To: SHIRE VIROPHARMA INCORPORATED
Reel/Frame 036075/0970 →
SECURITY INTEREST Recorded Mar 25, 2014
From: ALVOGEN INC.; ALMATICA PHARMA INC.
To: HSBC BANK USA, NATIONAL ASSOCIATION
Reel/Frame 032520/0278 →
RELEASE OF SECURITY INTEREST Recorded Jan 24, 2014
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: VIROPHARMA INCORPORATED
Reel/Frame 032036/0624 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 10, 2013
From: NORWICH PHARMACEUTICALS, INC.
To: VIROPHARMA INCORPORATED
Reel/Frame 029604/0615 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 10, 2013
From: BARNHART, PAUL; RUDY, JEFFERY A.; HALL, TODD M.
To: NORWICH PHARMACEUTICALS, INC.
Reel/Frame 029604/0498 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 10, 2013
From: DODSWORTH, DAVID W.; BRADLEY, JACK
To: VIROPHARMA INCORPORATED
Reel/Frame 029604/0667 →
SECURITY AGREEMENT Recorded Sep 12, 2011
From: VIROPHARMA INCORPORATED
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 026890/0303 →
Continuity (1)
Provisional Application 61094791 · Sep 5, 2008